Yes. The fact that there were no hyperplasias, EIN, or carcinomas far outweighs novel the novel cytopathology.
Proellex is a drug that affects the endometrium, of course it's going to have a structural effect. The fact that they're seeing poor secretory activity and apoptotic cells argues that this is a phenomenon associated with aging of a tissue that is normally turned over rapidly. I'd suspect that intermittent shedding with a pulsed dose will eliminate this issue.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.